Diffuse alveolar damage in nonresolving ARDS provides support for prolonged glucocorticoid treatment

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Intensive Care Medicine

• Publication date

  2015-05-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00134-015-3797-yPMID 25971378
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Open lung biopsy in nonresolving ARDS frequently identifies diffuse alveolar damage regardless of the severity stage and may have implications for patient management

  2015cited by this paper
• Understanding ARDS-associated fibroproliferation

  2015cited by this paper
• Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: a prospective cohort study of clinical autopsies.

  2013cited by this paper
• Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis*

  2009cited by this paper
• Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy.

  2009cited by this paper
• Efficacy and Safety of Corticosteroids for Persistent Acute Respiratory Distress Syndrome

  2009cited by this paper
• Low‐dose dexamethasone alleviates lipopolysaccharide‐induced acute lung injury in rats and upregulates pulmonary glucocorticoid receptors

  2008cited by this paper
• Steroid treatment for persistent ARDS: a word of caution

  2007cited by this paper
• Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.

  2006cited by this paper
• Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids.

  2002cited by this paper

• Effective and Safe Use of Glucocorticosteroids for Rescue of Late ARDS

  2017cites this paper
• DAD in nonresolving ARDS provides support for prolonged glucocorticoid treatment: a rebuttal

  2015cites this paper